Effects of combined immunosuppressant and hepatitis B virus antiviral use on COVID-19 vaccination in recipients of living donor liver transplantation

Additional COVID-19 vaccination is recommended for patients taking immunosuppressive drugs and hepatitis B antiviral drugs after LDLT.

Authors

Jung‐Man Namgoong (ORCID: https://orcid.org/0000-0002-9237-7440)
Ryunjin Lee
Gi‐Won Song (ORCID: https://orcid.org/0000-0002-4235-0434)
Eunkyeong Lee (ORCID: https://orcid.org/0000-0002-2106-2169)
Jiwan Choi
Gil‐Chun Park (ORCID: https://orcid.org/0000-0003-1631-3258)
Eunyoung Tak (ORCID: https://orcid.org/0000-0002-2595-3639)
Young‐In Yoon (ORCID: https://orcid.org/0000-0002-5306-912X)
Eun‐Kyoung Jwa (ORCID: https://orcid.org/0000-0003-4820-0039)
Seoon Kang (ORCID: https://orcid.org/0000-0002-3947-4129)
Jooyoung Lee (ORCID: https://orcid.org/0000-0002-7938-8196)
Sung‐Min Kim (ORCID: https://orcid.org/0000-0003-2079-6141)
Sung‐Han Kim (ORCID: https://orcid.org/0000-0002-6596-8253)
Sung‐Gyu Lee (ORCID: https://orcid.org/0000-0001-9161-3491)
Jiye Kim (ORCID: https://orcid.org/0000-0002-5758-6810)
Hye‐In An